
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
Timothy Aungst, PharmD, assistant professor of pharmacy practice at MCPHS University, talks about how the FDA currently regulates mHealth apps.
Timothy Aungst, PharmD, assistant professor of pharmacy practice at MCPHS University, talks about how the FDA currently regulates mHealth apps.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.






